All Publications

Data provided by UCSF Profiles, powered by CTSI at UCSF
  1. Fung M, Chiu CY, DeVoe C, Doernberg SB, Schwartz BS, Langelier C, Henrich TJ, Yokoe D, Davis J, Hays SR, Chandran S, Kukreja J, Ng D, Prostko J, Taylor R, Reyes K, Bainbridge E, Bond A, Chin-Hong P, Babik JM. Clinical Outcomes and Serologic Response in Solid Organ Transplant Recipients with COVID-19: A Case Series from the United States. Am J Transplant. 2020 Jun 01. View in PubMed
  2. Flavio Vincenti, Sindhu Chandran, David Wojciechowski, Chung Leung, Erica Tavares, Qizhi Tang, Jun Shoji. SP729CLINICAL AND IMMUNOLOGIC PREDICTORS OF OUTCOME WITH A NOVEL BELATACEPT REGIMEN. . 2018 May 1; 33(suppl_1):i592-i592. View in PubMed
  3. Flavio Vincenti, Sindhu Chandran, David Wojciechowski, Chung Leung, Erica Tavares, Qizhi Tang, Jun Shoji. SP729CLINICAL AND IMMUNOLOGIC PREDICTORS OF OUTCOME WITH A NOVEL BELATACEPT REGIMEN. Nephrology,Dialysis and Transplantation. 2018 May 1; 33(suppl_1):i592-i592. View in PubMed
  4. Wojciechowski D, Chandran S, Webber A, Hirose R, Vincenti F. Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients. Transplant Proc. 2017 Oct; 49(8):1773-1778. View in PubMed
  5. Chandran S, Tang Q, Sarwal M, Laszik ZG, Putnam AL, Lee K, Leung J, Nguyen V, Sigdel T, Tavares EC, Yang JYC, Hellerstein M, Fitch M, Bluestone JA, Vincenti F. Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants. Am J Transplant. 2017 Nov; 17(11):2945-2954. View in PubMed
  6. Wojciechowski D, Chandran S, Yang JYC, Sarwal MM, Vincenti F. Retrospective evaluation of the efficacy and safety of belatacept with thymoglobulin induction and maintenance everolimus: A single-center clinical experience. Clin Transplant. 2017 Sep; 31(9). View in PubMed
  7. Lee BJ, McCulloch CE, Grimes BA, Chandran S, Allen IE, Delgado C, Hsu CY. Refining the Policy for Timing of Kidney Transplant Waitlist Qualification. Transplant Direct. 2017 Aug; 3(8):e195. View in PubMed
  8. Abend JR, Changala M, Sathe A, Casey F, Kistler A, Chandran S, Howard A, Wojciechowski D. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients. Transplantation. 2017 06; 101(6):1495-1505. View in PubMed
  9. Wojciechowski D, Chandran S, Vincenti F. Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients. Clin Transplant. 2017 05; 31(5). View in PubMed
  10. Chandran S, Stock PG. Opportunities and Challenges for Kidney Donation from and to HIV-Positive Individuals. Clin J Am Soc Nephrol. 2017 03 07; 12(3):385-387. View in PubMed
  11. Sindhu Chandran,Flavio Vincenti. Chapter 21 Novel Drugs in Kidney Transplantation. . 2017 Jan 1; 277-290. View in PubMed
  12. Sindhu Chandran, Flavio Vincenti. Chapter 21 Novel Drugs in Kidney Transplantation. Kidney Transplantation, Bioengineering and Regeneration. 2017 Jan 1; 277-290. View in PubMed
  13. Chandran S, Feng S. Current status of tolerance in kidney transplantation. Curr Opin Nephrol Hypertens. 2016 11; 25(6):591-601. View in PubMed
  14. Wojciechowski D, Chandran S. BK Virus Infection After Kidney Transplantation: The Data Are Mounting for a Personalized Approach. Transplantation. 2016 Apr; 100(4):703-4. View in PubMed
  15. Morgan TA, Chandran S, Burger IM, Zhang CA, Goldstein RB. Complications of Ultrasound-Guided Renal Transplant Biopsies. Am J Transplant. 2016 Apr; 16(4):1298-305. View in PubMed
  16. Safa K, Chandran S, Wojciechowski D. Erratum to: Pharmacologic Targeting of Regulatory T Cells for Solid Organ Transplantation: Current and Future Prospects. Drugs. 2015 Dec; 75(18):2171. View in PubMed
  17. Safa K, Chandran S, Wojciechowski D. Pharmacologic targeting of regulatory T cells for solid organ transplantation: current and future prospects. Drugs. 2015 Nov; 75(16):1843-52. View in PubMed
  18. Raja Rajalingam, Sindhu Chandran, Kelly Cunniffe, Sandy Feng. Multiple high MFI Class I DSA can cause acute AMR of kidney allograft in simultaneous liver and kidney transplant recipients: outcome analysis from a single-center. . 2015 Oct 1; 76:137. View in PubMed
  19. Raja Rajalingam, Sindhu Chandran, Kelly Cunniffe, Sandy Feng. Multiple high MFI Class I DSA can cause acute AMR of kidney allograft in simultaneous liver and kidney transplant recipients: outcome analysis from a single-center. Human Immunology. 2015 Oct 1; 76:137. View in PubMed
  20. Wu EH, Wojciechowski D, Chandran S, Yeh BM, Park M, Westphalen A, Wang ZJ. Prevalence of abdominal aortic calcifications in older living renal donors and its effect on graft function and histology. Transpl Int. 2015 Oct; 28(10):1172-8. View in PubMed
  21. Flavio Vincenti, Qizhi Tang, Zoltan Laszik, Minnie Sarwal, Jeffrey Bluestone, Sindhu Chandran. FP886T REGULATORY CELL THERAPY TO CONTROL INFLAMMATION IN RENAL ALLOGRAFTS. Nephrology,Dialysis and Transplantation. 2015 May 1; 30(suppl_3):iii372-iii373. View in PubMed
  22. Flavio Vincenti, Qizhi Tang, Zoltan Laszik, Minnie Sarwal, Jeffrey Bluestone, Sindhu Chandran. FP886T REGULATORY CELL THERAPY TO CONTROL INFLAMMATION IN RENAL ALLOGRAFTS. . 2015 May 1; 30(suppl_3):iii372-iii373. View in PubMed
  23. S. Chandran, D. Arroyo, P. Vagefi, D. Wojciechowski. Adjuvant Ciprofloxacin Therapy for Refractory BK Polyomavirus Infection in Kidney Transplant Recipients. . 2014 Jul 1; 98:560. View in PubMed
  24. D. Wojciechowski, S. Chandran, F. Vincenti. Belatacept Conversion in Kidney Transplant Recipients for Prolonged DGF. . 2014 Jul 1; 98:456. View in PubMed
  25. D. Wojciechowski, S. Chandran, F. Vincenti. Novel Strategy to Improve the Efficacy of Belatacept. . 2014 Jul 1; 98:455. View in PubMed
  26. S. Chandran, D. Arroyo, P. Vagefi, D. Wojciechowski. Adjuvant Ciprofloxacin Therapy for Refractory BK Polyomavirus Infection in Kidney Transplant Recipients. Transplantation Journal. 2014 Jul 1; 98:560. View in PubMed
  27. D. Wojciechowski, S. Chandran, F. Vincenti. Belatacept Conversion in Kidney Transplant Recipients for Prolonged DGF. Transplantation Journal. 2014 Jul 1; 98:456. View in PubMed
  28. D. Wojciechowski, A. Webber, S. Chandran, R. Hirose, F. Vincenti. Everolimus Conversion to Treat BK Virus Infection in Renal Transplant Recipients: Interim Analysis of a Pilot Study. Transplantation Journal. 2014 Jul 1; 98:558-559. View in PubMed
  29. A. Webber, D. Wojciechowski, C. Leung, S. Chandran, R. Hirose, F. Vincenti. Pharmacodynamic Monitoring of NFAT- Regulated Gene Expression and P70S6 Kinase Activity in Kidney Transplant Patients With BKV Infection. Transplantation Journal. 2014 Jul 1; 98:880. View in PubMed
  30. D. Wojciechowski, S. Chandran, F. Vincenti. Novel Strategy to Improve the Efficacy of Belatacept. Transplantation Journal. 2014 Jul 1; 98:455. View in PubMed
  31. Arroyo D, Chandran S, Vagefi PA, Wojciechowski D. Adjuvant Ciprofloxacin for Persistent BK Polyomavirus Infection in Kidney Transplant Recipients. J Transplant. 2014; 2014:107459. View in PubMed
  32. Chandran S, Masharani U, Webber AB, Wojciechowski DM. Prediabetic living kidney donors have preserved kidney function at 10 years after donation. Transplantation. 2014 Apr 15; 97(7):748-54. View in PubMed
  33. Chandran S, Vincenti F. Clinical aspects: focusing on key unique organ-specific issues of renal transplantation. Cold Spring Harb Perspect Med. 2014 Feb 01; 4(2). View in PubMed
  34. Sindhu Chandran, Flavio G. Vincenti. 63 Immunosuppression in Transplantation. National Kidney Foundation Primer on Kidney Diseases. 2014 Jan 1; (Science2701995):564-574. View in PubMed
  35. Sindhu Chandran,Flavio G. Vincenti. 63 Immunosuppression in Transplantation. . 2014 Jan 1; (Science2701995):564-574. View in PubMed
  36. Wojciechowski D, Chandran S. Effect of ciprofloxacin combined with sulfamethoxazole-trimethoprim prophylaxis on the incidence of urinary tract infections after kidney transplantation. Transplantation. 2013 Aug 27; 96(4):400-5. View in PubMed
  37. Chandran S, Jen KY, Laszik ZG. Recurrent HIV-associated immune complex glomerulonephritis with lupus-like features after kidney transplantation. Am J Kidney Dis. 2013 Aug; 62(2):335-8. View in PubMed
  38. Wojciechowski D, Chanda R, Chandran S, Lee B, Webber A, Macaraig M, Tomlanovich S, Vincenti F. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year. Transplantation. 2012 Dec 15; 94(11):1117-23. View in PubMed
  39. Freed MM, Ramirez-Valle F, Chandran S. Fever, hepatosplenomegaly and a skin nodule in a kidney-pancreas transplant recipient. Am J Transplant. 2012 Sep; 12(9):2556-8; quiz 2558. View in PubMed
  40. Lockridge JB, Chandran S. The Scribner shunt: 50 years later. Kidney Int. 2012 Jan; 81(1):120. View in PubMed
  41. Chandran S, Li H, Dong W, Krasinska K, Adams C, Alexandrova L, Chien A, Hallows KR, Bhalla V. Neural precursor cell-expressed developmentally down-regulated protein 4-2 (Nedd4-2) regulation by 14-3-3 protein binding at canonical serum and glucocorticoid kinase 1 (SGK1) phosphorylation sites. J Biol Chem. 2011 Oct 28; 286(43):37830-40. View in PubMed
  42. Chandran S, Baxter-Lowe L, Olson JL, Tomlanovich SJ, Webber A. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report. Transplant Proc. 2011 Jun; 43(5):2097-101. View in PubMed
  43. Hallows KR, Bhalla V, Oyster NM, Wijngaarden MA, Lee JK, Li H, Chandran S, Xia X, Huang Z, Chalkley RJ, Burlingame AL, Pearce D. Phosphopeptide screen uncovers novel phosphorylation sites of Nedd4-2 that potentiate its inhibition of the epithelial Na+ channel. J Biol Chem. 2010 Jul 09; 285(28):21671-8. View in PubMed
  44. Chandran S, Petersen J, Jacobs C, Fiorentino D, Doeden K, Lafayette RA. Imatinib in the treatment of nephrogenic systemic fibrosis. Am J Kidney Dis. 2009 Jan; 53(1):129-32. View in PubMed
  45. Bose S, Chandran S, Mirocha JM, Bose N. The Akt pathway in human breast cancer: a tissue-array-based analysis. Mod Pathol. 2006 Feb; 19(2):238-45. View in PubMed